← Leaderboards
Saori Furuta
University Of Toledo Health Sci Campus
$2,184,263
Attributed
$2,184,263
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $575.7K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,184,263 · 2
By mechanism
R01$1,770,291 · 1
R21$413,972 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Prevention”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventionTranslational ImpactMammary Gland ParenchymaPreventReportingTetrahydrobiopterinImmunogenicityMalignant NeoplasmsMammary NeoplasmsNitric Oxide SynthasePublic HealthBreastArginineSepiapterinErbb2 GeneImmuneInnovationMacrophageAntitumor EffectCofactorMediatingMetabolismAnimalsTumor
Grant awards (7)
Roles of gut-breast axis in breast pathophysiology$188,169
R21 · FY2025 · CA · contact PI
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer$349,874
R01 · FY2024 · CA · contact PI
Roles of gut-breast axis in breast pathophysiology$225,803
R21 · FY2024 · CA · contact PI
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer$360,922
R01 · FY2023 · CA · contact PI
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer$353,419
R01 · FY2022 · CA · contact PI
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer$353,419
R01 · FY2021 · CA · contact PI
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer$352,657
R01 · FY2020 · CA · contact PI